Stress-induced sex differences: Adaptations mediated by the glucocorticoid receptor

Hormones and Behavior

Volumn 62, Issue 3, 2012, Pages 210-218

  Bourke, Chase H ^a   Harrell, Constance S ^a,b   Neigh, Gretchen N ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Georgia State University   (United States)

Author keywords

Anxiety; Autoimmunity; Cytokines; Estradiol; Glucocorticoid receptor; Obesity; Progesterone; Sex differences; Testosterone

Indexed keywords

BAG1 PROTEIN; CELL PROTEIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 51; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG;

ACUTE STRESS; BEHAVIOR CHANGE; CHRONIC STRESS; GENE EXPRESSION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; METABOLIC REGULATION; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SEX DIFFERENCE; SOCIAL INTERACTION; STRESS;

ADAPTATION, PHYSIOLOGICAL; BRAIN; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; SEX CHARACTERISTICS; STRESS, PSYCHOLOGICAL;

EID: 84866756414     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2012.02.024     Document Type: Review

References (120)

1. Agarwal S.K., Marshall G.D. Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. J. Interferon Cytokine Res. 1998, 18:1059-1068.
2. Ahmed S.A., Talal N. Sex hormones and the immune system-part 2. Animal data. Baillieres Clin. Rheumatol. 1990, 4:13-31.
3. Altemus M. Sex differences in depression and anxiety disorders: potential biological determinants. Horm. Behav. 2006, 50:534-538.
4. Angold A., Costello E.J., Worthman C.M. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol. Med. 1998, 28:51-61.
5. Armario A., Marti J., Gil M. The serum glucose response to acute stress is sensitive to the intensity of the stressor and to habituation. Psychoneuroendocrinology 1990, 15:341-347.
6. Avitsur R., Padgett D.A., Sheridan J.F. Social interactions, stress, and immunity. Neurol. Clin. 2006, 24:483-491.
7. Bagley S.L., Weaver T.L., Buchanan T.W. Sex differences in physiological and affective responses to stress in remitted depression. Physiol. Behav. 2011, 104:180-186.
8. Bale T.L., Vale W.W. Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: sexually dichotomous responses. J. Neurosci. 2003, 23:5295-5301.
9. Bangasser D.A., Curtis A., Reyes B.A., Bethea T.T., Parastatidis I., Ischiropoulos H., Van Bockstaele E.J., Valentino R.J. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol. Psychiatry 2010, 15(877):896-904.
10. Barrett K.B.S., Boitano S., Brooks H. Ganong's Review of Medical Physiology 2010, McGraw-Hill, New York. 23 ed. K.E. Barrett, S.M.B., S. Boitano, H. Brooks (Eds.).
11. Bebbington P., Dunn G., Jenkins R., Lewis G., Brugha T., Farrell M., Meltzer H. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Int. Rev. Psychiatry 2003, 15:74-83.
12. Bian C., Zhang D., Guo Q., Cai W., Zhang J. Localization and sex-difference of steroid receptor coactivator-1 immunoreactivities in the brain of adult female and male mice. Steroids 2011, 76:269-279.
13. Binder E.B. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009, 34(Suppl. 1):S186-S195.
14. Bjorntorp P., Rosmond R. The metabolic syndrome-a neuroendocrine disorder?. Br. J. Nutr. 2000, 83(Suppl. 1):S49-S57.
15. Bourke C.H., Neigh G.N. Behavioral effects of chronic adolescent stress are sustained and sexually dimorphic. Horm. Behav. 2011, 60:112-120.
16. Bourke C.H., Owens M.J. Corticotropin-releasing factor. Encyclopedia of Psychopharmacology 2010, 355-360. Springer. 1st ed.
17. Butts C.L., Bowers E., Horn J.C., Shukair S.A., Belyavskaya E., Tonelli L., Sternberg E.M. Inhibitory effects of progesterone differ in dendritic cells from female and male rodents. Gend. Med. 2008, 5:434-447.
18. Camacho-Arroyo I., Neri-Gomez T., Gonzalez-Arenas A., Guerra-Araiza C. Changes in the content of steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid hormone receptors in the rat brain during the estrous cycle. J. Steroid Biochem. Mol. Biol. 2005, 94:267-272.
19. Carpenter L.L., Carvalho J.P., Tyrka A.R., Wier L.M., Mello A.F., Mello M.F., Anderson G.M., Wilkinson C.W., Price L.H. Decreased adrenocorticotropic hormone and cortisol responses to stress in healthy adults reporting significant childhood maltreatment. Biol. Psychiatry 2007, 62:1080-1087.
20. Charlier T.D., Ball G.F., Balthazart J. Plasticity in the expression of the steroid receptor coactivator 1 in the Japanese quail brain: effect of sex, testosterone, stress and time of the day. Neuroscience 2006, 140:1381-1394.
21. Choudhry M.A., Schwacha M.G., Hubbard W.J., Kerby J.D., Rue L.W., Bland K.I., Chaudry I.H. Gender differences in acute response to trauma-hemorrhage. Shock 2005, 24(Suppl. 1):101-106.
22. Choudhry M.A., Bland K.I., Chaudry I.H. Trauma and immune response-effect of gender differences. Injury 2007, 38:1382-1391.
23. Conley C.S., Rudolph K.D. The emerging sex difference in adolescent depression: interacting contributions of puberty and peer stress. Dev. Psychopathol. 2009, 21:593-620.
24. Da Silva J.A. Sex hormones and glucocorticoids: interactions with the immune system. Ann. N. Y. Acad. Sci. 1999, 876:102-117. discussion 117-108.
25. Davies T.H., Ning Y.M., Sanchez E.R. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry (Mosc.) 2005, 44:2030-2038.
26. DeSantis S.M., Baker N.L., Back S.E., Spratt E., Ciolino J.D., Moran-Santa Maria M., Dipankar B., Brady K.T. Gender differences in the effect of early life trauma on hypothalamic-pituitary-adrenal axis functioning. Depress. Anxiety 2011, 28:383-392.
27. Desbonnet L., Garrett L., Daly E., McDermott K.W., Dinan T.G. Sexually dimorphic effects of maternal separation stress on corticotrophin-releasing factor and vasopressin systems in the adult rat brain. Int. J. Dev. Neurosci. 2008, 26:259-268.
28. Evuarherhe O., Leggett J., Waite E., Kershaw Y., Lightman S. Reversal of the hypothalamo-pituitary-adrenal response to oestrogens around puberty. J. Endocrinol. 2009, 202:279-285.
29. Figueiredo H.F., Dolgas C.M., Herman J.P. Stress activation of cortex and hippocampus is modulated by sex and stage of estrus. Endocrinology 2002, 143:2534-2540.
30. Gammie S.C., Hasen N.S., Stevenson S.A., Bale T.L., D'Anna K.L. Elevated stress sensitivity in corticotropin-releasing factor receptor 2 deficient mice decreases maternal, but not intermale aggression. Behav. Brain Res. 2005, 160:169-177.
31. Gehring U., Tomkins G.M. A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor. Cell 1974, 3:301-306.
32. Goel N., Bale T.L. Examining the intersection of sex and stress in modelling neuropsychiatric disorders. J. Neuroendocrinol. 2009, 21:415-420.
33. Goel N., Bale T.L. Sex differences in the serotonergic influence on the hypothalamic-pituitary-adrenal stress axis. Endocrinology 2010, 151:1784-1794.
34. Grad I., Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell. Endocrinol. 2007, 275:2-12.
35. Grossman C.J. Interactions between the gonadal steroids and the immune system. Science 1985, 227:257-261.
36. Hafner S., Emeny R.T., Lacruz M.E., Baumert J., Herder C., Koenig W., Thorand B., Ladwig K.H. Association between social isolation and inflammatory markers in depressed and non-depressed individuals: results from the MONICA/KORA study. Brain Behav. Immun. 2011, 25:1701-1707.
37. Hartmann J., Wagner K.V., Liebl C., Scharf S.H., Wang X.D., Wolf M., Hausch F., Rein T., Schmidt U., Touma C., Cheung-Flynn J., Cox M.B., Smith D.F., Holsboer F., Muller M.B., Schmidt M.V. The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology 2012, 62:332-339.
38. Heim C., Newport D.J., Miller A.H., Nemeroff C.B. Long-term neuroendocrine effects of childhood maltreatment. JAMA 2000, 284:2321.
39. Hubler T.R., Scammell J.G. Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 2004, 9:243-252.
40. Hubler T.R., Denny W.B., Valentine D.L., Cheung-Flynn J., Smith D.F., Scammell J.G. The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 2003, 144:2380-2387.
41. Huizenga N.A., Koper J.W., De Lange P., Pols H.A., Stolk R.P., Burger H., Grobbee D.E., Brinkmann A.O., De Jong F.H., Lamberts S.W. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J. Clin. Endocrinol. Metab. 1998, 83:144-151.
42. Iwasaki-Sekino A., Mano-Otagiri A., Ohata H., Yamauchi N., Shibasaki T. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology 2009, 34:226-237.
43. Jaaskelainen T., Makkonen H., Palvimo J.J. Steroid up-regulation of FKBP51 and its role in hormone signaling. Curr. Opin. Pharmacol. 2011, 11:326-331.
44. Kanelakis K.C., Morishima Y., Dittmar K.D., Galigniana M.D., Takayama S., Reed J.C., Pratt W.B. Differential effects of the hsp70-binding protein BAG-1 on glucocorticoid receptor folding by the hsp90-based chaperone machinery. J. Biol. Chem. 1999, 274:34134-34140.
45. Keck M.E., Wigger A., Welt T., Muller M.B., Gesing A., Reul J.M., Holsboer F., Landgraf R., Neumann I.D. Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 2002, 26:94-105.
46. Kendler K.S., Kuhn J.W., Prescott C.A. Childhood sexual abuse, stressful life events and risk for major depression in women. Psychol. Med. 2004, 34:1475-1482.
47. Kessler R.C. Epidemiology of women and depression. J. Affect. Disord. 2003, 74:5-13.
48. Knapp R.T., Steiner A., Schmidt U., Hafner K., Holsboer F., Rein T. BAG-1 diversely affects steroid receptor activity. Biochem. J. 2011.
49. Knee D.A., Froesch B.A., Nuber U., Takayama S., Reed J.C. Structure-function analysis of Bag1 proteins. Effects on androgen receptor transcriptional activity. J. Biol. Chem. 2001, 276:12718-12724.
50. Kontula K., Paavonen T., Luukkainen T., Andersson L.C. Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem. Pharmacol. 1983, 32:1511-1518.
51. Krishnan A.V., Swami S., Feldman D. Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 2001, 77:29-37.
52. Kudielka B.M., Buske-Kirschbaum A., Hellhammer D.H., Kirschbaum C. HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender. Psychoneuroendocrinology 2004, 29:83-98.
53. Kumar P., Mark P.J., Ward B.K., Minchin R.F., Ratajczak T. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 2001, 284:219-225.
54. Kumsta R., Entringer S., Koper J.W., van Rossum E.F., Hellhammer D.H., Wust S. Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress. Biol. Psychiatry 2007, 62:863-869.
55. Kunugi H., Ida I., Owashi T., Kimura M., Inoue Y., Nakagawa S., Yabana T., Urushibara T., Kanai R., Aihara M., Yuuki N., Otsubo T., Oshima A., Kudo K., Inoue T., Kitaichi Y., Shirakawa O., Isogawa K., Nagayama H., Kamijima K., Nanko S., Kanba S., Higuchi T., Mikuni M. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology 2006, 31:212-220.
56. Kurihara I., Shibata H., Suzuki T., Ando T., Kobayashi S., Hayashi M., Saito I., Saruta T. Expression and regulation of nuclear receptor coactivators in glucocorticoid action. Mol. Cell. Endocrinol. 2002, 189:181-189.
57. Lachize S., Apostolakis E.M., van der Laan S., Tijssen A.M., Xu J., de Kloet E.R., Meijer O.C. Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:8038-8042.
58. Lee R.S., Tamashiro K.L., Yang X., Purcell R.H., Harvey A., Willour V.L., Huo Y., Rongione M., Wand G.S., Potash J.B. Chronic corticosterone exposure increases expression and decreases deoxyribonucleic acid methylation of Fkbp5 in mice. Endocrinology 2010, 151:4332-4343.
59. Liman J., Ganesan S., Dohm C.P., Krajewski S., Reed J.C., Bahr M., Wouters F.S., Kermer P. Interaction of BAG1 and Hsp70 mediates neuroprotectivity and increases chaperone activity. Mol. Cell. Biol. 2005, 25:3715-3725.
60. Liman J., Faida L., Dohm C.P., Reed J.C., Bahr M., Kermer P. Subcellular distribution affects BAG1 function. Brain Res. 2008, 1198:21-26.
61. Liston C., Gan W.B. Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:16074-16079.
62. Maeng S., Hunsberger J.G., Pearson B., Yuan P., Wang Y., Wei Y., McCammon J., Schloesser R.J., Zhou R., Du J., Chen G., McEwen B., Reed J.C., Manji H.K. BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:8766-8771.
63. Manenschijn L., van den Akker E.L., Lamberts S.W., van Rossum E.F. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann. N. Y. Acad. Sci. 2009, 1179:179-198.
64. Marques A.H., Silverman M.N., Sternberg E.M. Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. Ann. N. Y. Acad. Sci. 2009, 1179:1-18.
65. Marquez C., Belda X., Armario A. Post-stress recovery of pituitary-adrenal hormones and glucose, but not the response during exposure to the stressor, is a marker of stress intensity in highly stressful situations. Brain Res. 2002, 926:181-185.
66. Matthews K.A., Gump B.B., Owens J.F. Chronic stress influences cardiovascular and neuroendocrine responses during acute stress and recovery, especially in men. Health Psychol. 2001, 20:403-410.
67. McMurray R.W., Wilson J.G., Bigler L., Xiang L., Lagoo A. Progesterone inhibits glucocorticoid-induced murine thymocyte apoptosis. Int. J. Immunopharmacol. 2000, 22:955-965.
68. McMurray R.W., Suwannaroj S., Ndebele K., Jenkins J.K. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels. Pathobiology 2001, 69:44-58.
69. McTernan P.G., Anderson L.A., Anwar A.J., Eggo M.C., Crocker J., Barnett A.H., Stewart P.M., Kumar S. Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: gender and site differences. J. Clin. Endocrinol. Metab. 2002, 87:1327-1336.
70. Meijer O.C., Kalkhoven E., van der Laan S., Steenbergen P.J., Houtman S.H., Dijkmans T.F., Pearce D., de Kloet E.R. Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling. Endocrinology 2005, 146:1438-1448.
71. Miller A.H., Pariante C.M., Pearce B.D. Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv. Exp. Med. Biol. 1999, 461:107-116.
72. Mitev Y.A., Wolf S.S., Almeida O.F., Patchev V.K. Developmental expression profiles and distinct regional estrogen responsiveness suggest a novel role for the steroid receptor coactivator SRC-1 as discriminative amplifier of estrogen signaling in the rat brain. FASEB J. 2003, 17:518-519.
73. Mong J.A., Baker F.C., Mahoney M.M., Paul K.N., Schwartz M.D., Semba K., Silver R. Sleep, rhythms, and the endocrine brain: influence of sex and gonadal hormones. J. Neurosci. 2011, 31:16107-16116.
74. Mueller B.R., Bale T.L. Impact of prenatal stress on long term body weight is dependent on timing and maternal sensitivity. Physiol. Behav. 2006, 88:605-614.
75. Neigh G.N., Gillespie C.F., Nemeroff C.B. The neurobiological toll of child abuse and neglect. Trauma Violence Abuse 2009, 10:389-410.
76. Olazabal U.E., Pfaff D.W., Mobbs C.V. Estrogenic regulation of heat shock protein 90kDa in the rat ventromedial hypothalamus and uterus. Mol. Cell. Endocrinol. 1992, 84:175-183.
77. Olazabal U.E., Pfaff D.W., Mobbs C.V. Sex differences in the regulation of heat shock protein 70kDa and 90kDa in the rat ventromedial hypothalamus by estrogen. Brain Res. 1992, 596:311-314.
78. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43:425-473.
79. Palanza P. Animal models of anxiety and depression: how are females different?. Neurosci. Biobehav. Rev. 2001, 25:219-233.
80. Pardridge W.M., Mietus L.J. Transport of steroid hormones through the rat blood-brain barrier. Primary role of albumin-bound hormone. J. Clin. Invest. 1979, 64:145-154.
81. Pariante C.M., Pearce B.D., Pisell T.L., Sanchez C.I., Po C., Su C., Miller A.H. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999, 140:4359-4366.
82. Periyasamy S., Warrier M., Tillekeratne M.P., Shou W., Sanchez E.R. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Endocrinology 2007, 148:4716-4726.
83. Periyasamy S., Hinds T., Shemshedini L., Shou W., Sanchez E.R. FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. Oncogene 2010, 29:1691-1701.
84. Rai D., Bhatia G., Sen T., Palit G. Comparative study of perturbations of peripheral markers in different stressors in rats. Can. J. Physiol. Pharmacol. 2003, 81:1139-1146.
85. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
86. Ratajczak T., Ward B.K., Minchin R.F. Immunophilin chaperones in steroid receptor signalling. Curr. Top. Med. Chem. 2003, 3:1348-1357.
87. Renoir J.M., Mercier-Bodard C., Hoffmann K., Le Bihan S., Ning Y.M., Sanchez E.R., Handschumacher R.E., Baulieu E.E. Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:4977-4981.
88. Reynolds R.M. Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes. J. Steroid Biochem. Mol. Biol. 2010, 122:3-9.
89. Rivest S., Deshaies Y., Richard D. Effects of corticotropin-releasing factor on energy balance in rats are sex dependent. Am. J. Physiol. 1989, 257:R1417-R1422.
90. Rohleder N., Schommer N.C., Hellhammer D.H., Engel R., Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom. Med. 2001, 63:966-972.
91. Roncari D.A., Van R.L. Promotion of human adipocyte precursor replication by 17beta-estradiol in culture. J. Clin. Invest. 1978, 62:503-508.
92. Rubinow D.R., Roca C.A., Schmidt P.J., Danaceau M.A., Putnam K., Cizza G., Chrousos G., Nieman L. Testosterone suppression of CRH-stimulated cortisol in men. Neuropsychopharmacology 2005, 30:1906-1912.
93. Scharf S.H., Liebl C., Binder E.B., Schmidt M.V., Muller M.B. Expression and regulation of the Fkbp5 gene in the adult mouse brain. PLoS One 2011, 6:e16883.
94. Schmidt U., Wochnik G.M., Rosenhagen M.C., Young J.C., Hartl F.U., Holsboer F., Rein T. Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor. J. Biol. Chem. 2003, 278:4926-4931.
95. Seale J.V., Wood S.A., Atkinson H.C., Bate E., Lightman S.L., Ingram C.D., Jessop D.S., Harbuz M.S. Gonadectomy reverses the sexually diergic patterns of circadian and stress-induced hypothalamic-pituitary-adrenal axis activity in male and female rats. J. Neuroendocrinol. 2004, 16:516-524.
96. Seale J.V., Wood S.A., Atkinson H.C., Harbuz M.S., Lightman S.L. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J. Neuroendocrinol. 2004, 16:989-998.
97. Shibuya N., Suzuki A., Sadahiro R., Kamata M., Matsumoto Y., Goto K., Hozumi Y., Otani K. Association study between a functional polymorphism of FK506-binding protein 51 (FKBP5) gene and personality traits in healthy subjects. Neurosci. Lett. 2010, 485:194-197.
98. Shors T.J., Chua C., Falduto J. Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J. Neurosci. 2001, 21:6292-6297.
99. Steptoe A., Wardle J. Cardiovascular stress responsivity, body mass and abdominal adiposity. Int. J. Obes. (Lond) 2005, 29:1329-1337.
100. Syed A.A., Irving J.A., Redfern C.P., Hall A.G., Unwin N.C., White M., Bhopal R.S., Weaver J.U. Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring) 2006, 14:759-764.
101. Tatro E.T., Everall I.P., Kaul M., Achim C.L. Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder. Brain Res. 2009, 1286:1-12.
102. Taylor S.E., Klein L.C., Lewis B.P., Gruenewald T.L., Gurung R.A., Updegraff J.A. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol. Rev. 2000, 107:411-429.
103. Ter Horst G.J., Wichmann R., Gerrits M., Westenbroek C., Lin Y. Sex differences in stress responses: focus on ovarian hormones. Physiol. Behav. 2009, 97:239-249.
104. Toufexis D.J., Davis C., Hammond A., Davis M. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J. Neurosci. 2004, 24:10280-10287.
105. Touma C., Gassen N.C., Herrmann L., Cheung-Flynn J., Bull D.R., Ionescu I.A., Heinzmann J.M., Knapman A., Siebertz A., Depping A.M., Hartmann J., Hausch F., Schmidt M.V., Holsboer F., Ising M., Cox M.B., Schmidt U., Rein T. FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol. Psychiatry 2011, 70:928-936.
106. Tranguch S., Cheung-Flynn J., Daikoku T., Prapapanich V., Cox M.B., Xie H., Wang H., Das S.K., Smith D.F., Dey S.K. Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14326-14331.
107. van Rossum E.F., Lamberts S.W. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog. Horm. Res. 2004, 59:333-357.
108. Vesga-Lopez O., Schneier F.R., Wang S., Heimberg R.G., Liu S.M., Hasin D.S., Blanco C. Gender differences in generalized anxiety disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). J. Clin. Psychiatry 2008, 69:1606-1616.
109. Vitaliano P.P., Scanlan J.M., Zhang J., Savage M.V., Hirsch I.B., Siegler I.C. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom. Med. 2002, 64:418-435.
110. Wagner U., Born J. Memory consolidation during sleep: interactive effects of sleep stages and HPA regulation. Stress 2008, 11:28-41.
111. Ward B.K., Mark P.J., Ingram D.M., Minchin R.F., Ratajczak T. Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer. Breast Cancer Res. Treat. 1999, 58:267-280.
112. Weinstock M. Gender differences in the effects of prenatal stress on brain development and behaviour. Neurochem. Res. 2007, 32:1730-1740.
113. Weiser M.J., Handa R.J. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009, 159:883-895.
114. Weiser M.J., Foradori C.D., Handa R.J. Estrogen receptor beta activation prevents glucocorticoid receptor-dependent effects of the central nucleus of the amygdala on behavior and neuroendocrine function. Brain Res. 2010, 1336:78-88.
115. Xu X.F., Hoebeke J., Bjorntorp P. Progestin binds to the glucocorticoid receptor and mediates antiglucocorticoid effect in rat adipose precursor cells. J. Steroid Biochem. 1990, 36:465-471.
116. Yang Y., Kozloski M. Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66:493-500.
117. Yudkin J.S., Kumari M., Humphries S.E., Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000, 148:209-214.
118. Zavala J.K., Fernandez A.A., Gosselink K.L. Female responses to acute and repeated restraint stress differ from those in males. Physiol. Behav. 2011, 104:215-221.
119. Zhang Y., Leung D.Y., Nordeen S.K., Goleva E. Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation. J. Biol. Chem. 2009, 284:24542-24552.
120. Zhou R., Gray N.A., Yuan P., Li X., Chen J., Chen G., Damschroder-Williams P., Du J., Zhang L., Manji H.K. The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J. Neurosci. 2005, 25:4493-4502.